você pode entrar em contato conosco da maneira que for conveniente para você. estamos disponíveis 24 horas por dia, 7 dias por semana por e-mail ou telefone.
China's intelligent manufacturing gains a foothold globally at ISTH 2025 Congress
June 25, 2025
The 33rd International Society on Thrombosis and Haemostasis (ISTH 2025) opened in Washington, USA, at 10:00 AM Eastern Time on June 22 (10:00 PM Beijing Time on June 23). Top global experts in thrombosis, hemostasis, and hematology gathered to exchange cutting-edge science, release the latest research findings, and discuss common topics such as new clinical applications and improving patient care.
At this grand event, "Chinese Smart Manufacturing" was showcased on the world stage. As the only company in China presenting independently innovative cell testing products, Poclight's platelet activation function detection product based on CRET cell technology received high praise and widespread attention from attending experts, thanks to its unique design concepts and technical highlights. In contrast, traditional testing methods are losing attention to emerging technologies, reflecting the urgent demand for innovative solutions in the field of clinical diagnostics.
In the field of platelet function testing, flow cytometry, as a new method, can detect platelet activation functions. However, its technical characteristics lead to complex operations, which cannot guarantee timeliness and also affect the stability of platelets. This results in test results that cannot reflect the true state of platelets in vivo, providing minimal benefit for clinical guidance. Aggregation instruments can only detect platelet aggregation functions, which are greatly influenced by platelet counts, making testing impossible for patients with low platelet counts. Poclight's innovative CRET cytometry combines activation and function testing while achieving POCT capabilities, making it a powerful tool to break through the challenges of timeliness and situational complexity! CRET cytometry perfectly achieves a dual breakthrough in testing efficiency and clinical practicality, turning the industry's dreams into reality and providing new ideas and tools for thrombosis and hemostasis research, showcasing unlimited potential!
Poclight's innovative CRET cell technology has achieved a breakthrough:
Integrated activation and functional detection
Break through the limitation of platelet count
Obtain quantitative results in as fast as 5 minutes
Truly achieve POCT detectionEasier operation, more real and reliable results